The influence of infection on hospital mortality for patients requiring > 48 h of intensive care.

OBJECTIVE To determine the influence of microbiologically confirmed infection on hospital mortality among patients requiring intensive care for > 48 h. DESIGN Prospective cohort study. SETTING Medical ICU of the Barnes-Jewish Hospital, an urban teaching hospital. PATIENTS A total of 893 patients requiring intensive care for > 48 h. INTERVENTIONS Prospective patient surveillance and data collection. MEASUREMENTS AND MAIN RESULTS Three hundred seventy-two patients (41.7%) requiring intensive care for > 48 h had a microbiologically confirmed infection. Only six patients (0.7% [1.6% of patients with microbiologically confirmed infections]) received inadequate antimicrobial therapy during the first 24 h of treatment, and 248 patients (27.8%) died during hospitalization. Compared to hospital survivors, hospital nonsurvivors were significantly more likely to have a microbiologically confirmed infection (53.2% vs 37.2%, respectively; p < 0.001) and to develop severe sepsis (45.6% vs 28.7%, respectively; p < 0.001). Cirrhosis and the requirement for vasopressors were the only variables identified by multiple logistic regression analysis as independent risk factors for hospital mortality in all patient groupings of severity of illness. Multiple logistic regression analysis also demonstrated that underlying malignancy (adjusted odds ratio [AOR], 1.98; 95% CI, 1.55 to 2.53), chronic renal insufficiency (AOR, 1.57; 95% CI, 1.31 to 1.87), cirrhosis (AOR, 1.94; 95% CI, 1.48 to 2.53), temperature > 38.3 degrees C (AOR, 1.72; 95% CI, 1.47 to 2.02), severe sepsis (AOR, 2.78; 95% CI, 1.94 to 3.98), positive culture for vancomycin-resistant enterococci (AOR, 1.78; 95% CI, 1.51 to 2.09), and the presence of multiple infections (AOR, 1.65; 95% CI, 1.28 to 2.14) were independently associated with the requirement for therapy with vasopressors. CONCLUSIONS Microbiologically confirmed infections are common among patients requiring medical intensive care for > 48 h. Despite the administration of adequate antimicrobial therapy, microbiologically confirmed infections appear to be an important cause of hemodynamic instability and increased hospital mortality. These data suggest that clinical efforts aimed at the prevention of infections and improvements in the medical management of patients with severe infections, especially those associated with hemodynamic instability and the need for vasopressors, are required to achieve further improvements in patient outcomes.

[1]  Marin H Kollef,et al.  Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. , 2002, Chest.

[2]  S. Fridkin,et al.  The Role of Understaffing in Central Venous Catheter-Associated Bloodstream Infection , 1996, Infection Control &#x0026; Hospital Epidemiology.

[3]  W. Knaus,et al.  APACHE II: a severity of disease classification system. , 1985 .

[4]  B. Yangco,et al.  CDC definitions for nosocomial infections. , 1989, American journal of infection control.

[5]  E. Hak,et al.  Introducing a pneumococcal vaccine to an existing influenza immunization program: vaccination rates and predictors of noncompliance. , 2001, The American journal of medicine.

[6]  T. Evans Hemodynamic and metabolic therapy in critically ill patients. , 2001, The New England journal of medicine.

[7]  J Ean,et al.  Efficacy and safety of recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.

[8]  M. Niederman Impact of antibiotic resistance on clinical outcomes and the cost of care , 2001, Critical care medicine.

[9]  J. A. N. Eedleman,et al.  Nurse-Staffing Levels and the Quality of Care in Hospitals , 2002 .

[10]  W. Bilker,et al.  Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  D. Gruson,et al.  Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria. , 2000, American journal of respiratory and critical care medicine.

[12]  M. Safar,et al.  Risk factors and outcome of nosocomial infections: results of a matched case-control study of ICU patients. , 1998, American journal of respiratory and critical care medicine.

[13]  H. Dupont,et al.  Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia , 2001, Intensive Care Medicine.

[14]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[15]  J. Vincent,et al.  The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. , 1995, JAMA.

[16]  J. Still,et al.  A Comparison of the Effect of Early Insertion of Standard Latex and Silver-Impregnated Latex Foley Catheters on Urinary Tract Infections in Burn Patients , 2002, Infection Control &#x0026; Hospital Epidemiology.

[17]  Victoria J. Fraser,et al.  Experience with a clinical guideline for the treatment of ventilator-associated pneumonia , 2001, Critical care medicine.

[18]  S. Black,et al.  Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. , 2002, The New England journal of medicine.

[19]  ICU-Acquired Pneumonia Study Group,et al.  Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit , 1996, Intensive Care Medicine.

[20]  J. Rello,et al.  The value of routine microbial investigation in ventilator-associated pneumonia. , 1997, American journal of respiratory and critical care medicine.

[21]  J. Garnacho-Montero,et al.  Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis* , 2003, Critical care medicine.

[22]  S. Cosgrove,et al.  Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species. , 2002, Archives of internal medicine.

[23]  G. Poland,et al.  Adult immunizations: recommendations for practice. , 1999, Mayo Clinic proceedings.

[24]  D. Green,et al.  Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome. , 1990, The Journal of clinical investigation.

[25]  M. Kollef,et al.  The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. , 1998, Chest.

[26]  Hajo A. Bruining,et al.  The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. , 1995 .

[27]  W. Trick,et al.  Control of vancomycin-resistant enterococcus in health care facilities in a region. , 2001, The New England journal of medicine.

[28]  Jordi Rello,et al.  Why do physicians not follow evidence-based guidelines for preventing ventilator-associated pneumonia?: a survey based on the opinions of an international panel of intensivists. , 2002, Chest.

[29]  M. Niederman,et al.  Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. , 1997, Chest.

[30]  M. Kollef,et al.  Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  J F Steiner,et al.  Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. , 1998, JAMA.

[32]  J M Hughes,et al.  CDC definitions for nosocomial infections, 1988. , 1988, American journal of infection control.

[33]  M. Fine,et al.  Quality of care, process, and outcomes in elderly patients with pneumonia. , 1997, JAMA.

[34]  M. Kollef,et al.  Antibiotic Resistance in the Intensive Care Unit , 2001, Annals of Internal Medicine.

[35]  E. Ivers,et al.  Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock , 2001 .

[36]  Patient Selection for Clinical Investigation of Ventilator-Associated Pneumonia: Criteria for Evaluating Diagnostic Techniques , 1992 .

[37]  D. Cook,et al.  The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. , 1999, American journal of respiratory and critical care medicine.

[38]  R. Gaynes,et al.  Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. , 1999, Critical care medicine.

[39]  J. Steiner,et al.  Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. , 1999, JAMA.

[40]  G Sherman,et al.  Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. , 1999, Chest.

[41]  J. Concato,et al.  The Risk of Determining Risk with Multivariable Models , 1993, Annals of Internal Medicine.